EE03487B1 - 5-fenüül-3-(piperidin-4-üül)-1,3,4-oksadiasol-2(3H)-ooni derivaadid kasutamiseks 5-HT4 - või H3- retseptorite ligandidena - Google Patents

5-fenüül-3-(piperidin-4-üül)-1,3,4-oksadiasol-2(3H)-ooni derivaadid kasutamiseks 5-HT4 - või H3- retseptorite ligandidena

Info

Publication number: EE03487B1
Authority: EE; Estonia
Prior art keywords: oxadiazol; piperidin; ligands; receptors; phenyl
Prior art date: 1995-11-09

Application number

EE9800155A

Other languages

English (en)

Other versions

EE9800155A (et

Inventor

Jegham Samir

Lochead Alistair

Galli Fr�d�ric

Nedelec Alain

Solignac Axelle

De Cruz Laurence

Original Assignee

Synthlabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-09

Filing date

1996-11-05

Publication date

2001-08-15

1995-11-09 Priority claimed from FR9513253A external-priority patent/FR2741070B1/fr

1995-11-09 Priority claimed from FR9513252A external-priority patent/FR2741069B1/fr

1996-03-04 Priority claimed from FR9602663A external-priority patent/FR2745574B1/fr

1996-11-05 Application filed by Synthlabo filed Critical Synthlabo

1998-12-15 Publication of EE9800155A publication Critical patent/EE9800155A/et

2001-08-15 Publication of EE03487B1 publication Critical patent/EE03487B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

EE9800155A 1995-11-09 1996-11-05 5-fenüül-3-(piperidin-4-üül)-1,3,4-oksadiasol-2(3H)-ooni derivaadid kasutamiseks 5-HT4 - või H3- retseptorite ligandidena EE03487B1 (et)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR9513253A FR2741070B1 (fr)	1995-11-09	1995-11-09	Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR9513252A FR2741069B1 (fr)	1995-11-09	1995-11-09	Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR9602663A FR2745574B1 (fr)	1996-03-04	1996-03-04	Derives de 5-phenyl-3-(piperidin-4-yl)-1, 3, 4-oxadiazol-2 (3h)-one, leur preparation et leur application en therapeutique
PCT/FR1996/001730 WO1997017345A1 (fr)	1995-11-09	1996-11-05	Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h¿3?

Publications (2)

Publication Number	Publication Date
EE9800155A EE9800155A (et)	1998-12-15
EE03487B1 true EE03487B1 (et)	2001-08-15

Family

ID=27253120

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9800155A EE03487B1 (et)	1995-11-09	1996-11-05	5-fenüül-3-(piperidin-4-üül)-1,3,4-oksadiasol-2(3H)-ooni derivaadid kasutamiseks 5-HT4 - või H3- retseptorite ligandidena

Country Status (29)

Country	Link
US (1)	US5929089A (et)
EP (1)	EP0863897B1 (et)
JP (1)	JP4263240B2 (et)
CN (1)	CN1077891C (et)
AR (1)	AR004708A1 (et)
AT (1)	ATE181328T1 (et)
AU (1)	AU707325B2 (et)
BG (1)	BG63463B1 (et)
BR (1)	BR9611311A (et)
CA (1)	CA2236357C (et)
CO (1)	CO4770968A1 (et)
CZ (1)	CZ287268B6 (et)
DE (1)	DE69602970T2 (et)
EE (1)	EE03487B1 (et)
ES (1)	ES2135934T3 (et)
GR (1)	GR3030823T3 (et)
HU (1)	HUP0001168A3 (et)
IL (1)	IL124364A (et)
MX (1)	MX9803696A (et)
NO (1)	NO309606B1 (et)
NZ (1)	NZ321626A (et)
PL (1)	PL186204B1 (et)
RU (1)	RU2167160C2 (et)
SI (1)	SI0863897T1 (et)
SK (1)	SK282335B6 (et)
TR (1)	TR199800827T2 (et)
TW (1)	TW371303B (et)
UA (1)	UA50748C2 (et)
WO (1)	WO1997017345A1 (et)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW467902B (en)	1996-07-31	2001-12-11	Bristol Myers Squibb Co	Diphenyl heterocycles as potassium channel modulators
FR2762316B1 (fr) *	1997-04-18	1999-12-17	Sanofi Synthelabo	Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2763068B1 (fr)	1997-05-06	1999-06-04	Synthelabo	Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
JP2002504896A (ja) *	1997-05-06	2002-02-12	サノフィ−サンテラボ	５−フェニル−１，３，４−オキサジアゾール−２（３ｈ）−オン誘導体およびそれらの５−ｈｔ４リガンドとしての使用
GB9715816D0 (en) *	1997-07-25	1997-10-01	Black James Foundation	Histamine H receptor ligands
US6960579B1 (en)	1998-05-19	2005-11-01	Alcon Manufacturing, Ltd.	Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TR200100754T2 (tr)	1998-09-18	2001-10-22	Alcon Laboratories, Inc.	Glausomanın tedavi edilmesi için serotonerjik 5HT2.
WO2000064441A2 (en) *	1999-04-28	2000-11-02	Respiratorius Ab	Compound for use as a medicament for treatment of disorders involving bronchocontraction
WO2000076500A2 (en) *	1999-06-15	2000-12-21	Respiratorius Ab	Compound for use as a medicament for treatment of disorders involving bronchocontraction
DK1313721T3 (da)	2000-08-08	2006-06-26	Ortho Mcneil Pharm Inc	Ikke-imidazol-aryloxyalkylaminer som H3-receptorligander
US6638967B2 (en)	2000-08-08	2003-10-28	Ortho-Mcneil Phamraceutical, Inc.	Thiophene of furan pyrrolidine compounds
PT1311482E (pt)	2000-08-08	2007-04-30	Ortho Mcneil Pharm Inc	Ariloxipiperidinas não imidazólicas como ligandos do receptor h3
ATE449090T1 (de)	2001-07-02	2009-12-15	High Point Pharmaceuticals Llc	Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
US7208497B2 (en)	2001-07-02	2007-04-24	Novo Nordisk A/S	Substituted piperazines and diazepanes
JP4619655B2 (ja)	2001-09-14	2011-01-26	ハイ・ポイント・ファーマスーティカルズ、エルエルシー	新規アミノアゼチジン、−ピロリジンおよび−ピペリジン誘導体
EP1434765B1 (en) *	2001-09-14	2009-12-02	High Point Pharmaceuticals, LLC	Substituted piperidines with selective binding to histamine h3-receptor
US6673829B2 (en)	2001-09-14	2004-01-06	Novo Nordisk A/S	Aminoazetidine,-pyrrolidine and -piperidine derivatives
US20030186963A1 (en)	2001-09-14	2003-10-02	Dorwald Florencio Zaragoza	Substituted piperidines
JP4563675B2 (ja)	2001-10-12	2010-10-13	ハイ・ポイント・ファーマスーティカルズ、エルエルシー	置換ピペリジン類、およびヒスタミンｈ３受容体関連疾患の治療のためのその使用
US7064135B2 (en)	2001-10-12	2006-06-20	Novo Nordisk Inc.	Substituted piperidines
WO2003051352A1 (en)	2001-12-14	2003-06-26	Alcon, Inc.	Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
US20030236259A1 (en) *	2002-02-05	2003-12-25	Rolf Hohlweg	Novel aryl- and heteroarylpiperazines
GB0211230D0 (en) *	2002-05-16	2002-06-26	Medinnova Sf	Treatment of heart failure
US7332508B2 (en)	2002-12-18	2008-02-19	Novo Nordisk A/S	Substituted homopiperidine, piperidine or pyrrolidine derivatives
GB0325956D0 (en) *	2003-11-06	2003-12-10	Addex Pharmaceuticals Sa	Novel compounds
US7737163B2 (en)	2004-06-15	2010-06-15	Pfizer Inc.	Benzimidazolone carboxylic acid derivatives
AU2005254800B2 (en)	2004-06-15	2010-12-09	Pfizer Inc.	Benzimidazolone carboxylic acid derivatives
EP2233470B1 (en) *	2005-07-04	2011-12-07	High Point Pharmaceuticals, LLC	Histamine H3 receptor antagonists
EP1959951B1 (en) *	2005-12-01	2009-12-23	F. Hoffmann-la Roche AG	Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
PT2079732E (pt)	2006-05-29	2012-02-02	High Point Pharmaceuticals Llc	3-(1,3-benzodioxol-5-il)-6-(4-ciclopropilpiperazin-1-il)- piridazina, os seus sais e solvatos e a sua utilização a título de antagonista do receptor h3 de histamina
EP2014656A3 (en) *	2007-06-11	2011-08-24	High Point Pharmaceuticals, LLC	New heteocyclic h3 antagonists
CN103380131B (zh) *	2011-09-19	2015-12-02	苏文生命科学有限公司	作为5-ht4受体配体的杂芳基化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5055476A (en) *	1990-08-13	1991-10-08	Hoechst-Roussel Pharmaceuticals Incorporated	3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
EP0600955A1 (en) *	1991-08-20	1994-06-15	Smithkline Beecham Plc	5-ht4 receptor antagonists
EP0604494B1 (en) *	1991-09-12	1999-07-28	Smithkline Beecham Plc	5-ht4 receptor antagonists
CA2129112A1 (en) *	1992-02-06	1993-08-19	Francis David King	Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists
GB9219163D0 (en) *	1992-09-10	1992-10-28	Smithkline Beecham Plc	Pharmaceuticals
JPH06157518A (ja) *	1992-11-27	1994-06-03	Yamanouchi Pharmaceut Co Ltd	新規なオキサジアゾール誘導体又はその塩

1996
- 1996-11-05 EP EP96937390A patent/EP0863897B1/fr not_active Expired - Lifetime
- 1996-11-05 EE EE9800155A patent/EE03487B1/et not_active IP Right Cessation
- 1996-11-05 AT AT96937390T patent/ATE181328T1/de active
- 1996-11-05 AU AU75001/96A patent/AU707325B2/en not_active Ceased
- 1996-11-05 SK SK599-98A patent/SK282335B6/sk not_active IP Right Cessation
- 1996-11-05 TR TR1998/00827T patent/TR199800827T2/xx unknown
- 1996-11-05 US US09/068,390 patent/US5929089A/en not_active Expired - Lifetime
- 1996-11-05 DE DE69602970T patent/DE69602970T2/de not_active Expired - Lifetime
- 1996-11-05 JP JP51791797A patent/JP4263240B2/ja not_active Expired - Fee Related
- 1996-11-05 CA CA002236357A patent/CA2236357C/en not_active Expired - Fee Related
- 1996-11-05 UA UA98031589A patent/UA50748C2/uk unknown
- 1996-11-05 NZ NZ321626A patent/NZ321626A/xx not_active IP Right Cessation
- 1996-11-05 BR BR9611311A patent/BR9611311A/pt not_active IP Right Cessation
- 1996-11-05 PL PL96326671A patent/PL186204B1/pl not_active IP Right Cessation
- 1996-11-05 WO PCT/FR1996/001730 patent/WO1997017345A1/fr not_active Ceased
- 1996-11-05 RU RU98110976/04A patent/RU2167160C2/ru not_active IP Right Cessation
- 1996-11-05 ES ES96937390T patent/ES2135934T3/es not_active Expired - Lifetime
- 1996-11-05 HU HU0001168A patent/HUP0001168A3/hu unknown
- 1996-11-05 SI SI9630092T patent/SI0863897T1/xx not_active IP Right Cessation
- 1996-11-05 CN CN96198208A patent/CN1077891C/zh not_active Expired - Fee Related
- 1996-11-05 CZ CZ19981421A patent/CZ287268B6/cs not_active IP Right Cessation
- 1996-11-05 IL IL12436496A patent/IL124364A/xx not_active IP Right Cessation
- 1996-11-07 TW TW085113594A patent/TW371303B/zh not_active IP Right Cessation
- 1996-11-08 CO CO96059097A patent/CO4770968A1/es unknown
- 1996-11-08 AR ARP960105098A patent/AR004708A1/es active IP Right Grant
1998
- 1998-04-28 BG BG102412A patent/BG63463B1/bg unknown
- 1998-05-07 NO NO982092A patent/NO309606B1/no not_active IP Right Cessation
- 1998-05-08 MX MX9803696A patent/MX9803696A/es unknown
1999
- 1999-07-20 GR GR990401913T patent/GR3030823T3/el unknown

Also Published As

Publication number	Publication date
NZ321626A (en)	1998-10-28
CZ287268B6 (en)	2000-10-11
EE9800155A (et)	1998-12-15
US5929089A (en)	1999-07-27
CO4770968A1 (es)	1999-04-30
EP0863897B1 (fr)	1999-06-16
AU707325B2 (en)	1999-07-08
CN1077891C (zh)	2002-01-16
IL124364A (en)	2001-08-08
AR004708A1 (es)	1999-03-10
SI0863897T1 (en)	1999-10-31
NO982092D0 (no)	1998-05-07
BR9611311A (pt)	1999-06-29
JP4263240B2 (ja)	2009-05-13
RU2167160C2 (ru)	2001-05-20
SK282335B6 (sk)	2002-01-07
NO982092L (no)	1998-06-29
NO309606B1 (no)	2001-02-26
SK59998A3 (en)	1998-11-04
WO1997017345A1 (fr)	1997-05-15
CZ142198A3 (cs)	1998-08-12
EP0863897A1 (fr)	1998-09-16
PL326671A1 (en)	1998-10-12
GR3030823T3 (en)	1999-11-30
HK1016165A1 (en)	1999-10-29
ES2135934T3 (es)	1999-11-01
DE69602970D1 (de)	1999-07-22
BG102412A (en)	1999-08-31
AU7500196A (en)	1997-05-29
ATE181328T1 (de)	1999-07-15
JP2000500125A (ja)	2000-01-11
UA50748C2 (uk)	2002-11-15
HUP0001168A3 (en)	2001-07-30
BG63463B1 (bg)	2002-02-28
TW371303B (en)	1999-10-01
PL186204B1 (pl)	2003-11-28
CA2236357A1 (en)	1997-05-15
HUP0001168A2 (hu)	2001-04-28
CA2236357C (en)	2006-10-17
IL124364A0 (en)	1998-12-06
TR199800827T2 (xx)	1999-02-22
DE69602970T2 (de)	2000-01-20
CN1202169A (zh)	1998-12-16
MX9803696A (es)	1998-09-30

Publication	Publication Date	Title
EE03487B1 (et)	2001-08-15	5-fenüül-3-(piperidin-4-üül)-1,3,4-oksadiasol-2(3H)-ooni derivaadid kasutamiseks 5-HT4 - või H3- retseptorite ligandidena
FI973205A0 (fi)	1997-08-01	Indolijohdannaisia 5-HT-reseptoriantagonisteina
ATE201016T1 (de)	2001-05-15	Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten
DE69719816D1 (de)	2003-04-17	N6-heterocyclisch substituierte Adenosin-Derivate
DK0708105T3 (da)	1999-08-23	5-HT4-receptoragonister
FR2637796B1 (fr)	1994-10-28	Charniere pour abattant de w.c.
DE69801905D1 (de)	2001-11-08	5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivate als 5-ht4 rezeptor liganden
KR970013921U (ko)	1997-04-28	건축용 다용도 브라켓
NO308035B1 (no)	2000-07-10	Substituerte tetracykliske azepinderivater som har affinitet for 5-HT2-reseptorer
MA23795A1 (fr)	1996-10-01	Derives d'indole substitues
BR9506518A (pt)	1997-09-02	Derivados de 3-aril-alquenil- 1,2,4-oxadiazol
DK0863897T3 (da)	2000-01-10	Derivater af 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-on, som kan anvendes som ligander for 5-HT4- eller H3-recept
ZA9600758D (en)	1997-09-30	Idole derivatives as 5-ht receptor antagonist.
FR2741069B1 (fr)	1997-12-12	Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR2741070B1 (fr)	1997-12-12	Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
AU7658898A (en)	1998-11-27	3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4ligands
FR2745574B1 (fr)	1998-04-03	Derives de 5-phenyl-3-(piperidin-4-yl)-1, 3, 4-oxadiazol-2 (3h)-one, leur preparation et leur application en therapeutique
FR2759699B1 (fr)	1999-03-19	Derives de 5-(2,3-dihydro-1,4-benzoxazin-5-yl)-3-(piperidin- 4-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
DK1133494T3 (da)	2004-06-14	8-Azabicyclo[3.2.1]oct-2-en-derivater
IT232910Y1 (it)	2000-01-21	supporto per strumenti odontoiatrici accessori.

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	HC1A	Change of owner name
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2014-08-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20131105